164 related articles for article (PubMed ID: 35831348)
1. Investigation on the cellular mechanism of Prunetin evidenced through next generation sequencing and bioinformatic approaches against gastric cancer.
Vetrivel P; Nachimuthu S; Abuyaseer A; Bhosale PB; Ha SE; Kim HH; Park MY; Kim GS
Sci Rep; 2022 Jul; 12(1):11852. PubMed ID: 35831348
[TBL] [Abstract][Full Text] [Related]
2. Compound Prunetin Induces Cell Death in Gastric Cancer Cell with Potent Anti-Proliferative Properties: In Vitro Assay, Molecular Docking, Dynamics, and ADMET Studies.
Vetrivel P; Kim SM; Ha SE; Kim HH; Bhosale PB; Senthil K; Kim GS
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708333
[TBL] [Abstract][Full Text] [Related]
3. Identification of Kynurenic Acid-Induced Apoptotic Biomarkers in Gastric Cancer-Derived AGS Cells through Next-Generation Transcriptome Sequencing Analysis.
Kim HH; Ha SE; Park MY; Jeong SH; Bhosale PB; Abusaliya A; Won CK; Heo JD; Ahn M; Seong JK; Kim HW; Kim GS
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615849
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic analysis of gene expression profiles of stomach carcinoma reveal abnormal expression of mitotic components.
Tong H; Wang J; Chen H; Wang Z; Fan H; Ni Z
Life Sci; 2017 Feb; 170():41-49. PubMed ID: 27923621
[TBL] [Abstract][Full Text] [Related]
5. Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy.
Xiao YF; Li BS; Liu JJ; Wang SM; Liu J; Yang H; Hu YY; Gong CL; Li JL; Yang SM
Clin Transl Med; 2022 Apr; 12(4):e691. PubMed ID: 35474446
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling and bioinformatics analysis of gastric carcinoma.
Liu N; Liu X; Zhou N; Wu Q; Zhou L; Li Q
Exp Mol Pathol; 2014 Jun; 96(3):361-6. PubMed ID: 24589858
[TBL] [Abstract][Full Text] [Related]
8. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
10. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
[No Abstract] [Full Text] [Related]
11. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
12. SSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway.
Liao J; Tao X; Ding Q; Liu J; Yang X; Yuan FE; Yang JA; Liu B; Xiang GA; Chen Q
Oncol Rep; 2017 Nov; 38(5):2667-2676. PubMed ID: 29048646
[TBL] [Abstract][Full Text] [Related]
13. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
[TBL] [Abstract][Full Text] [Related]
14. [Bioinformatics analysis of expression and function of EXD3 gene in gastric cancer].
Sun D; Liu M; Huang F; Huang F
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):215-221. PubMed ID: 30890511
[TBL] [Abstract][Full Text] [Related]
15. [Bioinformatics analysis of COL1A1 regulated by miR-129-5p as a potential therapeutic target for gastric cancer].
Yang W; Pan Y; Guan P; Li X; You C
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):540-546. PubMed ID: 31140417
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
[TBL] [Abstract][Full Text] [Related]
17. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.
Wang J; Sui Y; Li Q; Zhao Y; Dong X; Yang J; Liang Z; Han Y; Tang Y; Ma J
Cell Death Dis; 2020 Dec; 11(12):1029. PubMed ID: 33268769
[TBL] [Abstract][Full Text] [Related]
18. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
[TBL] [Abstract][Full Text] [Related]
19. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
20. Identification of early diagnostic biomarkers via WGCNA in gastric cancer.
Rezaei Z; Ranjbaran J; Safarpour H; Nomiri S; Salmani F; Chamani E; Larki P; Brunetti O; Silvestris N; Tavakoli T
Biomed Pharmacother; 2022 Jan; 145():112477. PubMed ID: 34864309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
